Literature DB >> 17150962

Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin.

Joachim H C Orth1, Klaus Aktories, Katharina F Kubatzky.   

Abstract

The Pasteurella multocida toxin (PMT) is highly mitogenic and has potential carcinogenic properties. PMT causes porcine atrophic rhinitis that is characterized by bone resorption and loss of nasal turbinates, but experimental nasal infection also leads to excess proliferation of bladder epithelial cells. PMT acts intracellularly and activates phospholipase C-linked signals and MAPK pathways via the heterotrimeric Galpha(q) and Galpha(12/13) proteins. We found that PMT induces activation of STAT proteins, and we identified STAT1, STAT3, and STAT5 as new targets of PMT-induced Galpha(q) signaling. Inhibition of Janus kinases completely abolished STAT activation. PMT-dependent STAT phosphorylation remained constitutive for at least 18 h. PMT caused down-regulation of the expression of the suppressor of cytokine signaling-3, indicating a novel mechanism to maintain activation of STATs. Moreover, stimulation of Swiss 3T3 cells with PMT increased transcription of the cancer-associated STAT-dependent gene cyclooxygenase-2. Because constitutive activation of STATs has been found in a number of cancers, our findings offer a new mechanism for a carcinogenic role of PMT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150962     DOI: 10.1074/jbc.M609018200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Toxin-induced RhoA activity mediates CCL1-triggered signal transducers and activators of transcription protein signaling.

Authors:  Simone Reipschläger; Katharina Kubatzky; Sanaz Taromi; Meike Burger; Joachim Orth; Klaus Aktories; Gudula Schmidt
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

Review 2.  Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Future Microbiol       Date:  2010-08       Impact factor: 3.165

3.  Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation.

Authors:  Joachim H C Orth; Inga Preuss; Ines Fester; Andreas Schlosser; Brenda A Wilson; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-15       Impact factor: 11.205

Review 4.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

Review 5.  Bacterial protein toxins that modify host regulatory GTPases.

Authors:  Klaus Aktories
Journal:  Nat Rev Microbiol       Date:  2011-06-16       Impact factor: 60.633

Review 6.  Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

Review 7.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 8.  Implications of non-canonical G-protein signaling for the immune system.

Authors:  Cédric Boularan; John H Kehrl
Journal:  Cell Signal       Date:  2014-02-28       Impact factor: 4.315

9.  Effector prediction in host-pathogen interaction based on a Markov model of a ubiquitous EPIYA motif.

Authors:  Shunfu Xu; Chao Zhang; Yi Miao; Jianjiong Gao; Dong Xu
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

10.  Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins.

Authors:  Joachim H C Orth; Ines Fester; Peter Siegert; Markus Weise; Ulrike Lanner; Shigeki Kamitani; Taro Tachibana; Brenda A Wilson; Andreas Schlosser; Yasuhiko Horiguchi; Klaus Aktories
Journal:  FASEB J       Date:  2012-11-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.